Abstract:Background
Massive vaccination rollouts against SARS-CoV-2 infections have facilitated the easing of control measures in countries like Israel. While several studies have characterized the effectiveness of vaccines against severe forms of COVID-19 or SARS-CoV-2 infection, estimates of their impact on transmissibility remain limited. Here, we evaluated the role of vaccination and isolation on SARS-CoV-2 transmission within Israeli households.
Methods
From December 2020 to April 2021, confirmed cases were identi… Show more
“…Further, Painter et al (2021) reported a key observation: rapid and universal induction of SARS-CoV-2-specific CD4+ T-cells after the first mRNA vaccine dose in naive individuals [106]. This observation is extremely important given the gradual development of antigen-specific CD8+ T-cells also observed by other groups [107,108], which reach maximal levels after the second vaccine dose.…”
Section: The Immunity and Virus Transmission After Vaccinationmentioning
confidence: 94%
“…In addition, much evidence has demonstrated that they can considerably reduce the risk of SARS-CoV-2 transmission. Concerning the protective effect, vaccinated individuals who become infected are up to 78% less likely to spread the virus to household members than unvaccinated people [106].…”
Section: The Immunity and Virus Transmission After Vaccinationmentioning
Due to its leading role in fighting infections, the human immune system has been the focus of many studies in the context of Coronavirus disease 2019 (COVID-19). In a worldwide effort, the scientific community has transitioned from reporting about the effects of the novel coronavirus on the human body in the early days of the pandemic to exploring the body’s many immunopathological and immunoprotecting properties that have improved disease treatment and enabled the development of vaccines. The aim of this review is to explain what happens to the immune system after recovery from COVID-19 and/or vaccination against SARS-CoV-2, the virus that causes the disease. We detail the way in which the immune system responds to a SARS-CoV-2 infection, including innate and adaptive measures. Then, we describe the role of vaccination, the main types of COVID-19 vaccines and how they protect us. Further, we explain the reason why immunity after COVID-19 infection plus a vaccination appears to induce a stronger response compared with virus exposure alone. Additionally, this review reports some correlates of protection from SARS-CoV-2 infection. In conclusion, we reinforce that vaccination is safe and important in achieving herd immunity.
“…Further, Painter et al (2021) reported a key observation: rapid and universal induction of SARS-CoV-2-specific CD4+ T-cells after the first mRNA vaccine dose in naive individuals [106]. This observation is extremely important given the gradual development of antigen-specific CD8+ T-cells also observed by other groups [107,108], which reach maximal levels after the second vaccine dose.…”
Section: The Immunity and Virus Transmission After Vaccinationmentioning
confidence: 94%
“…In addition, much evidence has demonstrated that they can considerably reduce the risk of SARS-CoV-2 transmission. Concerning the protective effect, vaccinated individuals who become infected are up to 78% less likely to spread the virus to household members than unvaccinated people [106].…”
Section: The Immunity and Virus Transmission After Vaccinationmentioning
Due to its leading role in fighting infections, the human immune system has been the focus of many studies in the context of Coronavirus disease 2019 (COVID-19). In a worldwide effort, the scientific community has transitioned from reporting about the effects of the novel coronavirus on the human body in the early days of the pandemic to exploring the body’s many immunopathological and immunoprotecting properties that have improved disease treatment and enabled the development of vaccines. The aim of this review is to explain what happens to the immune system after recovery from COVID-19 and/or vaccination against SARS-CoV-2, the virus that causes the disease. We detail the way in which the immune system responds to a SARS-CoV-2 infection, including innate and adaptive measures. Then, we describe the role of vaccination, the main types of COVID-19 vaccines and how they protect us. Further, we explain the reason why immunity after COVID-19 infection plus a vaccination appears to induce a stronger response compared with virus exposure alone. Additionally, this review reports some correlates of protection from SARS-CoV-2 infection. In conclusion, we reinforce that vaccination is safe and important in achieving herd immunity.
“…Early experience in the era of Alpha, when most vaccinated individuals had received their vaccines only in recent months, showed lower viral loads in those with breakthrough infections 42 , and measured viral RNA levels were correlated with low antibody levels around the time of infection 45 . Soon after vaccination and in the era of Alpha, vaccination reduced household transmission to unvaccinated individuals 96 . Evidence on the infectiousness of Delta variant breakthrough cases remains limited.…”
Section: Impact Of Breakthrough Infectionsmentioning
Breakthrough infections with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in fully vaccinated individuals are receiving intense scrutiny because of their importance in determining how long restrictions to control virus transmission will need to remain in place in highly vaccinated populations as well as in determining the need for additional vaccine doses or changes to the vaccine formulations and/or dosing intervals. Measurement of breakthrough infections is challenging outside of randomized, placebo-controlled, double-blind field trials. However, laboratory and observational studies are necessary to understand the impact of waning immunity, viral variants and other determinants of changing vaccine effectiveness against various levels of coronavirus disease 2019 (COVID-19) severity. Here, we describe the approaches being used to measure vaccine effectiveness and provide a synthesis of the burgeoning literature on the determinants of vaccine effectiveness and breakthrough rates. We argue that, rather than trying to tease apart the contributions of factors such as age, viral variants and time since vaccination, the rates of breakthrough infection are best seen as a consequence of the level of immunity at any moment in an individual, the variant to which that individual is exposed and the severity of disease being considered. We also address key open questions concerning the transition to endemicity, the potential need for altered vaccine formulations to track viral variants, the need to identify immune correlates of protection, and the public health challenges of using various tools to counter breakthrough infections, including boosters in an era of global vaccine shortages.
“…2 Vaccination also prevents transmission, according to three studies conducted before the onset of the Delta strain. [3][4][5] The BNT162b2 vaccine prevented 80% of infections, and although the decrease in transmission rate in vaccinated people varied from 40% to 80% in these studies, the combined effect resulted in >88% lower risk of SARS-CoV-2 transmission within households.…”
Section: Covid-19 Vaccines Protect Against Emerging Variantsmentioning
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.